152 related articles for article (PubMed ID: 38665620)
1. Comparison of baseline patient characteristics in Italian oncology drug monitoring registries and clinical trials: a real-world cross-sectional study.
Iacovino ML; Celant S; Tomassini L; Arenare L; Caglio A; Canciello A; Salerno F; Olimpieri PP; Di Segni S; Sferrazza A; Piccirillo MC; Beretta GD; Pinto C; Blasi L; Cinieri S; Cavanna L; Di Maio M; Russo P; Perrone F
Lancet Reg Health Eur; 2024 Jun; 41():100912. PubMed ID: 38665620
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. Italian cancer figures, report 2012: Cancer in children and adolescents.
; ;
Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
[TBL] [Abstract][Full Text] [Related]
4. MONITORING REGISTRIES AT ITALIAN MEDICINES AGENCY: FOSTERING ACCESS, GUARANTEEING SUSTAINABILITY.
Montilla S; Xoxi E; Russo P; Cicchetti A; Pani L
Int J Technol Assess Health Care; 2015 Jan; 31(4):210-3. PubMed ID: 26646859
[TBL] [Abstract][Full Text] [Related]
5. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
[TBL] [Abstract][Full Text] [Related]
6. Drug utilization, safety, and effectiveness of exenatide, sitagliptin, and vildagliptin for type 2 diabetes in the real world: data from the Italian AIFA Anti-diabetics Monitoring Registry.
Montilla S; Marchesini G; Sammarco A; Trotta MP; Siviero PD; Tomino C; Melchiorri D; Pani L;
Nutr Metab Cardiovasc Dis; 2014 Dec; 24(12):1346-53. PubMed ID: 25300980
[TBL] [Abstract][Full Text] [Related]
7. The Italian Fibromyalgia Registry: a new way of using routine real-world data concerning patient-reported disease status in healthcare research and clinical practice.
Salaffi F; Farah S; Di Carlo M; Sinigaglia L; Galeazzi M; Gerli R; Sonnati M; Giorgi V; Sarzi-Puttini P; Masullo M;
Clin Exp Rheumatol; 2020; 38 Suppl 123(1):65-71. PubMed ID: 32116213
[TBL] [Abstract][Full Text] [Related]
8. Non-vitamin K antagonist oral anticoagulation agents in patients with atrial fibrillation: Insights from Italian monitoring registries.
Olimpieri PP; Di Lenarda A; Mammarella F; Gozzo L; Cirilli A; Cuomo M; Gulizia MM; Colivicchi F; Murri G; Gabrielli D; Trotta F
Int J Cardiol Heart Vasc; 2020 Feb; 26():100465. PubMed ID: 32021902
[TBL] [Abstract][Full Text] [Related]
9. Mortality rate in patients with chronic myeloid leukemia in chronic phase treated with frontline second generation tyrosine kinase inhibitors: a retrospective analysis by the monitoring registries of the Italian Medicines Agency (AIFA).
Breccia M; Celant S; Olimpieri PP; Olimpieri OM; Pane F; Iurlo A; Cirilli A; Colatrella A; Gozzo L; Pugliese S; Summa V; Foggi P; Corradini P; Russo P;
Ann Hematol; 2021 Feb; 100(2):481-485. PubMed ID: 33415425
[TBL] [Abstract][Full Text] [Related]
10. Management of chronic myeloid leukaemia patients treated with ponatinib in a real-life setting: A retrospective analysis from the monitoring registries of the Italian Medicines Agency (AIFA).
Breccia M; Olimpieri PP; Celant S; Olimpieri O; Pane F; Iurlo A; Summa V; Corradini P; Russo P
Br J Haematol; 2022 Sep; 198(6):965-973. PubMed ID: 35904979
[TBL] [Abstract][Full Text] [Related]
11. The Evolution of AIFA Registries to Support Managed Entry Agreements for Orphan Medicinal Products in Italy.
Xoxi E; Facey KM; Cicchetti A
Front Pharmacol; 2021; 12():699466. PubMed ID: 34456724
[TBL] [Abstract][Full Text] [Related]
12. Real-World Effectiveness of PCSK9 Inhibitors in Reducing LDL-C in Patients With Familial Hypercholesterolemia in Italy: A Retrospective Cohort Study Based on the AIFA Monitoring Registries.
Arca M; Celant S; Olimpieri PP; Colatrella A; Tomassini L; D'Erasmo L; Averna M; Zambon A; Catapano AL; Russo P
J Am Heart Assoc; 2023 Nov; 12(21):e026550. PubMed ID: 37850449
[TBL] [Abstract][Full Text] [Related]
13. High prevalence of poor quality drug prescribing in older individuals: a nationwide report from the Italian Medicines Agency (AIFA).
Onder G; Bonassi S; Abbatecola AM; Folino-Gallo P; Lapi F; Marchionni N; Pani L; Pecorelli S; Sancarlo D; Scuteri A; Trifirò G; Vitale C; Zuccaro SM; Bernabei R; Fini M;
J Gerontol A Biol Sci Med Sci; 2014 Apr; 69(4):430-7. PubMed ID: 23913935
[TBL] [Abstract][Full Text] [Related]
14. [EMA approval procedures and assessment of innovation by AIFA: a cross sectional analysis.].
Lasala R
Recenti Prog Med; 2021 Apr; 112(4):273-284. PubMed ID: 33877088
[TBL] [Abstract][Full Text] [Related]
15. [Meta-analysis of the Italian studies on short-term effects of air pollution].
Biggeri A; Bellini P; Terracini B;
Epidemiol Prev; 2001; 25(2 Suppl):1-71. PubMed ID: 11515188
[TBL] [Abstract][Full Text] [Related]
16. Generalizability of clinical trial efficacy results to a real-world population: An example in migraine prevention.
Paget MA; Tockhorn-Heidenreich A; Belger M; Chartier F; Lantéri-Minet M
J Manag Care Spec Pharm; 2023 Dec; 29(12):1321-1330. PubMed ID: 38058137
[TBL] [Abstract][Full Text] [Related]
17. How many chronic myeloid leukemia patients who started a frontline second-generation tyrosine kinase inhibitor have to switch to a second-line treatment? A retrospective analysis from the monitoring registries of the italian medicines agency (AIFA).
Breccia M; Olimpieri PP; Olimpieri O; Pane F; Iurlo A; Foggi P; Cirilli A; Colatrella A; Cuomo M; Gozzo L; Summa V; Corradini P; Russo P;
Cancer Med; 2020 Jun; 9(12):4160-4165. PubMed ID: 32319737
[TBL] [Abstract][Full Text] [Related]
18. Trabectedin use in soft-tissue sarcoma patients in a real-world setting: Data from an Italian national drug-access registry.
Vincenzi B; Napolitano A; Comandone A; Sanfilippo R; Celant S; Olimpieri PP; Di Segni S; Russo P; Casali PG
Int J Cancer; 2023 Feb; 152(4):761-768. PubMed ID: 36196483
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the representativeness and generalizability of Japanese clinical trials for localized rectal/colon cancer: Comparing participants in the Japan Clinical Oncology Group study with patients in Japanese registries.
Miyamoto K; Wakabayashi M; Mizusawa J; Nakamura K; Katayama H; Higashi T; Inomata M; Kitano S; Fujita S; Kanemitsu Y; Fukuda H
Eur J Surg Oncol; 2020 Sep; 46(9):1642-1648. PubMed ID: 32340817
[TBL] [Abstract][Full Text] [Related]
20. Italian cancer figures, report 2014: Prevalence and cure of cancer in Italy.
AIRTUM Working Group
Epidemiol Prev; 2014; 38(6 Suppl 1):1-122. PubMed ID: 25759295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
